BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kovacsics D, Patik I, Özvegy-Laczka C. The role of organic anion transporting polypeptides in drug absorption, distribution, excretion and drug-drug interactions. Expert Opin Drug Metab Toxicol 2017;13:409-24. [PMID: 27783531 DOI: 10.1080/17425255.2017.1253679] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 7.2] [Reference Citation Analysis]
Number Citing Articles
1 Breidenbach JD, French BW, Gordon TT, Kleinhenz AL, Khalaf FK, Willey JC, Hammersley JR, Mark Wooten R, Crawford EL, Modyanov NN, Malhotra D, Teeguarden JG, Haller ST, Kennedy DJ. Microcystin-LR aerosol induces inflammatory responses in healthy human primary airway epithelium. Environ Int 2022;169:107531. [PMID: 36137425 DOI: 10.1016/j.envint.2022.107531] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Pavlič R, Gjorgoska M, Rižner TL. Model Cell Lines and Tissues of Different HGSOC Subtypes Differ in Local Estrogen Biosynthesis. Cancers (Basel) 2022;14:2583. [PMID: 35681563 DOI: 10.3390/cancers14112583] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Wang Z, Fang X, Zhang S, Song J. Pulmonary inflammation caused by cigarette smoke combined with lipopolysaccharide up-regulated OATP2B1 in rat lung tissue and pulmonary epithelial cells. Exp Lung Res 2022;:1-12. [PMID: 35441577 DOI: 10.1080/01902148.2022.2066223] [Reference Citation Analysis]
4 Chen J, Xue Y, Shuai X, Ni C, Fang Z, Ye L, Hong M. Effect of major components of Tripterygium wilfordii Hook. f on the uptake function of organic anion transporting polypeptide 1B1. Toxicol Appl Pharmacol 2021;435:115848. [PMID: 34958783 DOI: 10.1016/j.taap.2021.115848] [Reference Citation Analysis]
5 Birceanu O, Tessier LR, Huerta B, Li W, Mcdonald A, Wilkie MP. At the intersection between toxicology and physiology: What we have learned about sea lampreys and bony fish physiology from studying the mode of action of lampricides. Journal of Great Lakes Research 2021;47:S673-S689. [DOI: 10.1016/j.jglr.2021.07.007] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Laczkó-Rigó R, Bakos É, Jójárt R, Tömböly C, Mernyák E, Özvegy-Laczka C. Selective antiproliferative effect of C-2 halogenated 13α-estrones on cells expressing Organic anion-transporting polypeptide 2B1 (OATP2B1). Toxicol Appl Pharmacol 2021;429:115704. [PMID: 34474082 DOI: 10.1016/j.taap.2021.115704] [Reference Citation Analysis]
7 Ambrus C, Bakos É, Sarkadi B, Özvegy-Laczka C, Telbisz Á. Interactions of anti-COVID-19 drug candidates with hepatic transporters may cause liver toxicity and affect pharmacokinetics. Sci Rep 2021;11:17810. [PMID: 34497279 DOI: 10.1038/s41598-021-97160-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
8 Traj P, Abdolkhaliq AH, Németh A, Dajcs ST, Tömösi F, Lanisnik-Rizner T, Zupkó I, Mernyák E. Transition metal-catalysed A-ring C-H activations and C(sp2)-C(sp2) couplings in the 13α-oestrone series and in vitro evaluation of antiproliferative properties. J Enzyme Inhib Med Chem 2021;36:895-902. [PMID: 33771084 DOI: 10.1080/14756366.2021.1900165] [Reference Citation Analysis]
9 Martínez-Chávez A, Broeders J, Lebre MC, Tibben MT, Rosing H, Beijnen JH, Schinkel AH. The role of drug efflux and uptake transporters ABCB1 (P-gp), ABCG2 (BCRP) and OATP1A/1B and of CYP3A4 in the pharmacokinetics of the CDK inhibitor milciclib. Eur J Pharm Sci 2021;159:105740. [PMID: 33524505 DOI: 10.1016/j.ejps.2021.105740] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Telbisz Á, Ambrus C, Mózner O, Szabó E, Várady G, Bakos É, Sarkadi B, Özvegy-Laczka C. Interactions of Potential Anti-COVID-19 Compounds with Multispecific ABC and OATP Drug Transporters. Pharmaceutics 2021;13:81. [PMID: 33435273 DOI: 10.3390/pharmaceutics13010081] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 20.0] [Reference Citation Analysis]
11 Telbisz Á, Ambrus C, Mózner O, Szabó E, Várady G, Bakos É, Sarkadi B, Özvegy-laczka C. Interactions of anti-COVID-19 drug candidates with multispecific ABC and OATP drug transporters.. [DOI: 10.1101/2020.11.21.392555] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Bakos É, Tusnády GE, Német O, Patik I, Magyar C, Németh K, Kele P, Özvegy-Laczka C. Synergistic transport of a fluorescent coumarin probe marks coumarins as pharmacological modulators of Organic anion-transporting polypeptide, OATP3A1. Biochem Pharmacol 2020;182:114250. [PMID: 32991865 DOI: 10.1016/j.bcp.2020.114250] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
13 Buxhofer-Ausch V, Német O, Sheikh M, Andrikovics H, Reiner A, Ausch C, Mechtcheriakova D, Tordai A, Gleiss A, Özvegy-Laczka C, Jäger W, Thalhammer T. Two common polymorphic variants of OATP4A1 as potential risk factors for colorectal cancer. Oncol Lett 2020;20:252. [PMID: 32994815 DOI: 10.3892/ol.2020.12115] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Unger MS, Schumacher L, Enzlein T, Weigt D, Zamek-gliszczynski MJ, Schwab M, Nies AT, Drewes G, Schulz S, Reinhard FBM, Hopf C. Direct Automated MALDI Mass Spectrometry Analysis of Cellular Transporter Function: Inhibition of OATP2B1 Uptake by 294 Drugs. Anal Chem 2020;92:11851-9. [DOI: 10.1021/acs.analchem.0c02186] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Mohos V, Fliszár-Nyúl E, Ungvári O, Bakos É, Kuffa K, Bencsik T, Zsidó BZ, Hetényi C, Telbisz Á, Özvegy-Laczka C, Poór M. Effects of Chrysin and Its Major Conjugated Metabolites Chrysin-7-Sulfate and Chrysin-7-Glucuronide on Cytochrome P450 Enzymes and on OATP, P-gp, BCRP, and MRP2 Transporters. Drug Metab Dispos 2020;48:1064-73. [PMID: 32661014 DOI: 10.1124/dmd.120.000085] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]
16 Tupova L, Hirschmugl B, Sucha S, Pilarova V, Székely V, Bakos É, Novakova L, Özvegy-Laczka C, Wadsack C, Ceckova M. Interplay of drug transporters P-glycoprotein (MDR1), MRP1, OATP1A2 and OATP1B3 in passage of maraviroc across human placenta. Biomed Pharmacother 2020;129:110506. [PMID: 32768979 DOI: 10.1016/j.biopha.2020.110506] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
17 Ali Y, Shams T, Wang K, Cheng Z, Li Y, Shu W, Bao X, Zhu L, Murray M, Zhou F. The involvement of human organic anion transporting polypeptides (OATPs) in drug-herb/food interactions. Chin Med 2020;15:71. [PMID: 32670395 DOI: 10.1186/s13020-020-00351-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
18 Laczkó-rigó R, Jójárt R, Mernyák E, Bakos É, Tuerkova A, Zdrazil B, Özvegy-laczka C. Structural dissection of 13-epiestrones based on the interaction with human Organic anion-transporting polypeptide, OATP2B1. The Journal of Steroid Biochemistry and Molecular Biology 2020;200:105652. [DOI: 10.1016/j.jsbmb.2020.105652] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
19 Székely V, Patik I, Ungvári O, Telbisz Á, Szakács G, Bakos É, Özvegy-Laczka C. Fluorescent probes for the dual investigation of MRP2 and OATP1B1 function and drug interactions. Eur J Pharm Sci 2020;151:105395. [PMID: 32473861 DOI: 10.1016/j.ejps.2020.105395] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
20 Schäfer AM, Meyer Zu Schwabedissen HE, Bien-Möller S, Hubeny A, Vogelgesang S, Oswald S, Grube M. OATP1A2 and OATP2B1 Are Interacting with Dopamine-Receptor Agonists and Antagonists. Mol Pharm 2020;17:1987-95. [PMID: 32343897 DOI: 10.1021/acs.molpharmaceut.0c00159] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
21 Ambjørner SEB, Wiese M, Köhler SC, Svindt J, Lund XL, Gajhede M, Saaby L, Brodin B, Rump S, Weigt H, Brünner N, Stenvang J. The Pyrazolo[3,4-d]pyrimidine Derivative, SCO-201, Reverses Multidrug Resistance Mediated by ABCG2/BCRP. Cells 2020;9:E613. [PMID: 32143347 DOI: 10.3390/cells9030613] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
22 Helal NA, Eassa HA, Amer AM, Eltokhy MA, Edafiogho I, Nounou MI. Nutraceuticals' Novel Formulations: The Good, the Bad, the Unknown and Patents Involved. Recent Pat Drug Deliv Formul 2019;13:105-56. [PMID: 31577201 DOI: 10.2174/1872211313666190503112040] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 26.5] [Reference Citation Analysis]
23 Aithal GP, Kullak‐ublick GA. Drug Interactions in the Liver. The Liver 2020. [DOI: 10.1002/9781119436812.ch82] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Hanna PE, Anders MW. The mercapturic acid pathway. Crit Rev Toxicol 2019;49:819-929. [PMID: 31944156 DOI: 10.1080/10408444.2019.1692191] [Cited by in Crossref: 34] [Cited by in F6Publishing: 14] [Article Influence: 17.0] [Reference Citation Analysis]
25 Lu D, Chen M, Wang Y, Chen M, Wu B. Circadian Clock and Uptake Transporters. Circadian Pharmacokinetics 2020. [DOI: 10.1007/978-981-15-8807-5_7] [Reference Citation Analysis]
26 Bakos É, Német O, Patik I, Kucsma N, Várady G, Szakács G, Özvegy‐laczka C. A novel fluorescence‐based functional assay for human OATP1A2 and OATP1C1 identifies interaction between third‐generation P‐gp inhibitors and OATP1A2. FEBS J 2020;287:2468-85. [DOI: 10.1111/febs.15156] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
27 García-Lino AM, Álvarez-Fernández I, Blanco-Paniagua E, Merino G, Álvarez AI. Transporters in the Mammary Gland-Contribution to Presence of Nutrients and Drugs into Milk. Nutrients 2019;11:E2372. [PMID: 31590349 DOI: 10.3390/nu11102372] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 8.7] [Reference Citation Analysis]
28 Pan G. Roles of Hepatic Drug Transporters in Drug Disposition and Liver Toxicity. Adv Exp Med Biol 2019;1141:293-340. [PMID: 31571168 DOI: 10.1007/978-981-13-7647-4_6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
29 Holt K, Nagar S, Korzekwa K. Methods to Predict Volume of Distribution. Curr Pharmacol Rep 2019;5:391-399. [DOI: 10.1007/s40495-019-00186-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
30 Alonso-Peña M, Espinosa-Escudero RA, Soto-Muñiz M, Sanchon-Sanchez P, Sanchez-Martin A, Marin JJ. Role of transportome in the pharmacogenomics of hepatocellular carcinoma and hepatobiliary cancer. Pharmacogenomics 2019;20:957-70. [PMID: 31486734 DOI: 10.2217/pgs-2019-0033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
31 Andrade RJ, Chalasani N, Björnsson ES, Suzuki A, Kullak-Ublick GA, Watkins PB, Devarbhavi H, Merz M, Lucena MI, Kaplowitz N, Aithal GP. Drug-induced liver injury. Nat Rev Dis Primers 2019;5:58. [PMID: 31439850 DOI: 10.1038/s41572-019-0105-0] [Cited by in Crossref: 215] [Cited by in F6Publishing: 229] [Article Influence: 71.7] [Reference Citation Analysis]
32 Wilkie MP, Hubert TD, Boogaard MA, Birceanu O. Control of invasive sea lampreys using the piscicides TFM and niclosamide: Toxicology, successes & future prospects. Aquatic Toxicology 2019;211:235-52. [DOI: 10.1016/j.aquatox.2018.12.012] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 12.0] [Reference Citation Analysis]
33 Windt T, Tóth S, Patik I, Sessler J, Kucsma N, Szepesi Á, Zdrazil B, Özvegy-Laczka C, Szakács G. Identification of anticancer OATP2B1 substrates by an in vitro triple-fluorescence-based cytotoxicity screen. Arch Toxicol 2019;93:953-64. [PMID: 30863990 DOI: 10.1007/s00204-019-02417-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
34 de Klerk DJ, Honeywell RJ, Jansen G, Peters GJ. Transporter and Lysosomal Mediated (Multi)drug Resistance to Tyrosine Kinase Inhibitors and Potential Strategies to Overcome Resistance. Cancers (Basel). 2018;10. [PMID: 30544701 DOI: 10.3390/cancers10120503] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 7.5] [Reference Citation Analysis]
35 Jójárt R, Pécsy S, Keglevich G, Szécsi M, Rigó R, Özvegy-Laczka C, Kecskeméti G, Mernyák E. Pd-Catalyzed microwave-assisted synthesis of phosphonated 13α-estrones as potential OATP2B1, 17β-HSD1 and/or STS inhibitors. Beilstein J Org Chem 2018;14:2838-45. [PMID: 30498534 DOI: 10.3762/bjoc.14.262] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
36 Hladky SB, Barrand MA. Elimination of substances from the brain parenchyma: efflux via perivascular pathways and via the blood-brain barrier. Fluids Barriers CNS 2018;15:30. [PMID: 30340614 DOI: 10.1186/s12987-018-0113-6] [Cited by in Crossref: 97] [Cited by in F6Publishing: 101] [Article Influence: 24.3] [Reference Citation Analysis]
37 Navrátilová L, Applová L, Horký P, Mladěnka P, Pávek P, Trejtnar F. Interaction of soy isoflavones and their main metabolites with hOATP2B1 transporter. Naunyn-Schmiedeberg's Arch Pharmacol 2018;391:1063-71. [DOI: 10.1007/s00210-018-1528-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
38 Cacabelos R. Population-level pharmacogenomics for precision drug development in dementia. Expert Review of Precision Medicine and Drug Development 2018;3:163-88. [DOI: 10.1080/23808993.2018.1468218] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
39 Chu X, Chan GH, Evers R. Identification of Endogenous Biomarkers to Predict the Propensity of Drug Candidates to Cause Hepatic or Renal Transporter-Mediated Drug-Drug Interactions. Journal of Pharmaceutical Sciences 2017;106:2357-67. [DOI: 10.1016/j.xphs.2017.04.007] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 9.4] [Reference Citation Analysis]
40 Lin S, Lin C, Yang J. Rifamycin SV MMX for the treatment of traveler’s diarrhea. Expert Opinion on Pharmacotherapy 2017;18:1269-1277. [DOI: 10.1080/14656566.2017.1353079] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
41 Rižner TL, Thalhammer T, Özvegy-Laczka C. The Importance of Steroid Uptake and Intracrine Action in Endometrial and Ovarian Cancers. Front Pharmacol 2017;8:346. [PMID: 28674494 DOI: 10.3389/fphar.2017.00346] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]